⌘K

Login Start Free

Home/Filings/4/0001209191-16-156235

4//SEC Filing

RXi Pharmaceuticals Corp 4

Accession 0001209191-16-156235

$PHIOCIK 0001533040operating

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 9:25 PM ET

Size

6.8 KB

Accession

0001209191-16-156235

Insider Transaction Report

Form 4

Period: 2016-12-16

RXi Pharmaceuticals CorpRXII

Chief Development Officer

Transactions

Award
Common stock warrant
2016-12-16+11,111→ 11,111 total
Exercise: $0.90From: 2016-12-21Exp: 2021-12-21→ Common stock (11,111 underlying)
Award
Common stock, $0.0001 par value
2016-12-16$0.90/sh+11,111$10,000→ 17,173 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RXi Pharmaceuticals Corp

CIK 0001533040

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001533040

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 9:25 PM ET
Size: 6.8 KB

View on SEC.gov